Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
APRIL 2021LIFE SCIENCES REVIEW6In the last 12 months, the life sciences industry has undoubtedly made remarkable strides to help "humanity" weather the pandemic storm on a global scale. For the first time in decades, we saw companies and regulators alike work in liaison to accelerate testing and introduce treatments and vaccines while ensuring safety at all times.Another unprecedented change worth mentioning was the industry attitude towards automation and cloud technologies--which went from boxes on a checklist to a must-have to support regulatory and safety compliance and deliver positive health outcomes. Until recently, most of the industry relied upon the legacy, disparate safety systems for adverse event monitoring and report management, with little or no innovation for decades together. The pandemic exposed the inefficiencies of these tools, making it abundantly clear that companies would need better, more advanced safety systems and processes to stay on par with increasing data volume, analytical, and regulatory requirements. Today's situation has highlighted the need for life sciences-focused, purpose-built AI-powered SaaS solutions that leverage machine learning and natural language processing capabilities for safety and pharmacovigilance teams to identify, capture, share, analyze, and report patient data from across multiple domains. Additionally, AI-powered tools can help life sciences companies gather, analyze, and evaluate patient reactions to medications, which subsequently optimizes the vaccine therapy development process. However, proving the accuracy of the data gathered or delivered by these tools to governments and regulators would remain a challenge. Nevertheless, the industry is en route to implement authority-facing strategies to address this challenge and use AI- and ML-backed solutions for other facets of life sciences--ensuring patient safety. In 2021 and beyond, digital transformation within the life sciences industry is set to take center stage--implying that changes brought forth by the pandemic were just the tip of the iceberg. Technology will continue to play a pivotal role in helping life sciences companies introduce treatments quickly and at scale while adhering to stringent safety and regulatory norms. This edition aims to provide readers insights from industry leaders to help them have a detailed understanding of the life sciences arena and the recent developments in this field.Let us know your thoughts.EDITORIALComplying with the Post-Pandemic EraCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Contact Us:Phone:510-230-0395Fax:510-894-8405Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com April - 5 - 2021, Vol 02, Issue - 02 Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersRonald Donovan*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsSalesStephen Thomassales@lifesciencesreview.comDean WinchesterPrevent FallsJust as it's important to know if patients are taking their medication, WalkWise® allows care providers to ensure 24/7 walker use.Enable preventative careOur patented algorithms allow you to screen for UTIs and other illnesses.Respond to EmergenciesFamilies and care providers can receive alerts if the walker tips over or remains inactive for a number of hours.A new spin onRemote Patient Monitoring. Learn about reimbursement and home health solutions from WalkWise®[smart walker attachment]®walkwise.com/healthcare | (866) 624.0046 | info@walkwise.com |®Asher Blake
< Page 5 | Page 7 >